Oral hypoglycemic Flashcards

1
Q

What are the main classifications of oral hypoglycaemics?

A
  1. Insulin secretagogues
  2. Biguanides
  3. Insulin sensitizers
  4. α-glucosidase inhibitors
  5. GLP-1 analogs
  6. Dipeptidyl peptidase-IV (DPP-IV) inhibitors
  7. Amylin antagonists

These classifications help in understanding the different mechanisms of action and therapeutic uses of oral hypoglycaemics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are insulin secretagogues?

A

They are drugs that stimulate insulin secretion from the pancreas.

Examples include sulfonylureas and meglitinides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name two examples of sulfonylureas.

A
  • Tolbutamide
  • Glibenclamide

Sulfonylureas are used to lower blood glucose levels in type 2 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action (MOA) of biguanides?

A

They reduce hepatic glucose production and enhance tissue sensitivity to insulin.

Metformin is the only marketed biguanide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prototype structure that defines meglitinides?

A

Meglitinide

Meglitinides are insulin secretagogues that stimulate insulin release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What distinguishes nateglinide from other meglitinides?

A

It is a phenylalanine analog of meglitinide and selectively binds to the SUR1 on β-cells.

Nateglinide is used to control blood sugar levels in diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the only clinically used drug in the thiazolidinedione family?

A

Pioglitazone

It is metabolized mainly through oxidative pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fill in the blank: Acarbose is a competitive inhibitor for ______.

A

sucrase

Acarbose is an α-glucosidase inhibitor derived from Actinomyces utahensis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do GLP-1 analogs function?

A

They emulate the function of GLP-1 peptide to control glucose levels by promoting insulin secretion only when glucose level is high.

This mechanism is important for preventing excessive insulin release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is required for the activity of DPP-IV inhibitors?

A

A basic amino function in the structure.

DPP-IV inhibitors are used in managing type 2 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: Amylin agonists inhibit gastric emptying and prevent postprandial rise in glucagon.

A

True

Amylin agonists also help with caloric intake and potential weight gain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the role of a-glucosidase in the body?

A

It is a membrane-bound enzyme that consists of maltase, sucrase, isomaltase, and glucoamylase.

Inhibiting this enzyme can help manage carbohydrate absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main action of insulin sensitizers?

A

They enhance insulin sensitivity in tissues.

This class includes drugs like glitazones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of drug is linagliptin?

A

A DPP-IV inhibitor and xanthine derivative used for type 2 diabetes.

It can be used alone or in combination with other medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fill in the blank: The only marketed biguanide is ______.

A

Metformin

Metformin is widely used for managing type 2 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action of amylin agonists?

A

They modulate gastric emptying, prevent postprandial rise in glucagon, and inhibit caloric intake.

They are administered via subcutaneous route.

17
Q

What are the two main types of insulin secretagogues?

A
  • Sulfonylureas
  • Meglitinides

Both classes stimulate insulin release from the pancreas.

18
Q

What is the main effect of α-glucosidase inhibitors?

A

They slow down carbohydrate absorption in the intestines.

This helps in controlling postprandial blood glucose levels.